Andrew H Kang Selected Research

Collagen Type II (Type II Collagen)

10/2017	The Role of Leukocyte-Associated Ig-like Receptor-1 in Suppressing Collagen-Induced Arthritis.
6/2012	Molecular basis for T cell response induced by altered peptide ligand of type II collagen.
5/2012	Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
9/2011	T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.
4/2010	Collagen-induced arthritis.
1/2010	Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.
10/2009	T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.
1/2007	An altered peptide ligand of type II collagen suppresses autoimmune arthritis.
9/2006	Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
1/2006	Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew H Kang Research Topics

Disease

22	Arthritis (Polyarthritis) 12/2021 - 01/2002
17	Experimental Arthritis 12/2021 - 01/2002
12	Rheumatoid Arthritis 12/2021 - 01/2002
6	Inflammation (Inflammations) 12/2021 - 03/2002
6	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 01/2002
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 06/2008
1	Necrosis 01/2006
1	Osteoarthritis 03/2002

Drug/Important Bio-Agent (IBA)

19	Collagen Type II (Type II Collagen)IBA 10/2017 - 01/2002
13	Peptides (Polypeptides)IBA 12/2016 - 12/2002
8	CytokinesIBA 12/2021 - 01/2002
7	AntigensIBA 01/2014 - 01/2004
5	HLA-DR1 Antigen (HLA DR1 Antigen)IBA 01/2014 - 12/2002
3	LigandsIBA 12/2016 - 01/2007
3	Interleukin-4 (Interleukin 4)IBA 12/2016 - 01/2006
3	CollagenIBA 01/2014 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 01/2007 - 01/2004
3	HLA-DR Antigens (HLA-DR)IBA 06/2004 - 01/2002
2	AntibodiesIBA 12/2021 - 06/2004
2	Interleukin-10 (Interleukin 10)IBA 12/2016 - 01/2006
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2006 - 04/2004
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2021
1	hydroxide ionIBA 12/2021
1	20-hydroxyvitamin D3IBA 12/2021
1	Vitamin D FDA LinkGeneric 12/2021
1	Immunoglobulin G (IgG)IBA 10/2017
1	Syk KinaseIBA 12/2016
1	Fc Receptors (Fc Receptor)IBA 09/2011
1	Freund's AdjuvantIBA 04/2010
1	Collagen Type I (Type I Collagen)IBA 06/2008
1	AutoantigensIBA 01/2007
1	Immunodominant EpitopesIBA 09/2006
1	diacetylfluorescein (fluorescein diacetate)IBA 01/2006
1	EstersIBA 01/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2006
1	Interleukin-2 (IL2)IBA 01/2006
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2006
1	Cyanogen BromideIBA 11/2004
1	Immunoglobulins (Immunoglobulin)IBA 11/2004
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2004
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2004
1	Lysine (L-Lysine)FDA Link 03/2004
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2002
1	EpitopesIBA 03/2002
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2002
1	Matrix Metalloproteinases (MMPs)IBA 03/2002
1	EnzymesIBA 03/2002
1	Peptide Hydrolases (Proteases)FDA Link 03/2002
1	TolerogenIBA 01/2002

Therapy/Procedure

4	Therapeutics 12/2021 - 01/2010
1	Immunotherapy 01/2007